Complex Generics May Need New Communications Options In GDUFA III

 
• By Derrick Gingery
Agreement business handshake partnership deal as a solution strategy with a team coming together out of tangled twisted roads on to a bridge to find a common goal.
The FDA and complex generic sponsors are looking for more opportunities to discuss scientific questions and potentially streamline the assessment process. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics